AVEO Pharmaceuticals, Inc. (AVEO) was a big mover last session, as its shares rose over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend for the healthcare company since March 10, as the stock is down over 7%.
In the last 30-day frame, the company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
AVEO Pharmaceuticals currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include Cambrex Corporation. (CBM), Alkermes plc (ALKS) and Alexion Pharmaceuticals, Inc. (ALXN). While Alexion and Alkermes sport a Zacks Rank #1 (Strong Buy), Cambrex carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
AVEO PHARMACEUTICALS INC (AVEO): Free Stock Analysis Report
ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report
ALKERMES PLC ORD (ALKS): Free Stock Analysis Report
CAMBREX CORP (CBM): Free Stock Analysis Report
Zacks Investment Research